[NEU] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[NEU] Neuren Pharmaceuticals Limited
Announcement Date
29-Dec-2023
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 128.59%
YoY- 1,409.75%
Quarter Report
NEU's Result
NEU's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
Revenue 24,327 168,999 62,926 14,553 0 3,197 0 -
PBT 11,843 155,501 49,622 6,374 -7,054 -3,027 -7,964 -
Tax 3,827 46,225 1,817 -864 0 -3,197 0 -
NP 8,016 109,276 47,805 7,238 -7,054 170 -7,964 -
Tax Rate -32.31% -29.73% -3.66% 13.56% - - - -
Total Cost 16,311 59,723 15,121 7,315 7,054 3,027 7,964 26.96%
Ratio Analysis
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
NP Margin 32.95 64.66 75.97 49.74 0.00 5.32 0.00 -
Per Share
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
EPS 0.06 0.86 0.38 0.06 -0.06 0.00 -0.07 -
EPS Diluted 0.06 0.83 0.37 0.06 -0.06 0.00 -0.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.